Compare CODA & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CODA | NSPR |
|---|---|---|
| Founded | 1994 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.9M | 81.8M |
| IPO Year | N/A | N/A |
| Metric | CODA | NSPR |
|---|---|---|
| Price | $9.33 | $2.01 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 48.1K | ★ 64.4K |
| Earning Date | 01-28-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.09 | N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $24,347,217.00 | $7,779,000.00 |
| Revenue This Year | $30.82 | $22.76 |
| Revenue Next Year | $20.84 | $75.45 |
| P/E Ratio | $31.80 | ★ N/A |
| Revenue Growth | ★ 29.34 | 14.04 |
| 52 Week Low | $5.76 | $1.59 |
| 52 Week High | $10.54 | $3.80 |
| Indicator | CODA | NSPR |
|---|---|---|
| Relative Strength Index (RSI) | 54.68 | 47.94 |
| Support Level | $9.15 | $1.89 |
| Resistance Level | $9.69 | $2.17 |
| Average True Range (ATR) | 0.41 | 0.14 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 69.47 | 50.00 |
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.